Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2023-07-17 00:00:00 ET · period of report 2023-07-14 · accession 0001654954-23-009269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-17 | 2023-07-14 | AEHR | SLAYEN HOWARD T | Dir | M - OptEx | $1.73 | +60.9K | 156.0K | +64% | +$105.3K |
| DM | 2023-07-17 | 2023-07-14 | AEHR | SLAYEN HOWARD T | Dir | M - OptEx | $0.00 | -60.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-14 | M | A | 14,711 | $1.86 | 196,875 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-14 | M | A | 10,000 | $1.77 | 166,004 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-14 | M | A | 16,160 | $1.64 | 182,164 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-14 | M | A | 10,000 | $1.34 | 206,875 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 5 | Common | Common Stock | 2023-07-14 | M | A | 10,000 | $2.03 | 156,004 | D | — | — | |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-07-14 | M | D | 10,000 | $0.00 | 0 | D | $2.03 · 2018-11-23 to 2025-11-23 | 10,000 Common Stock | (F2) One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-07-14 | M | D | 14,711 | $0.00 | 0 | D | $1.86 · 2020-07-14 to 2027-07-14 | 14,711 Common Stock | (F3) Total number of shares became exercisable on this date. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-07-14 | M | D | 10,000 | $0.00 | 0 | D | $1.77 · 2019-11-22 to 2026-10-22 | 10,000 Common Stock | (F2) One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-07-14 | M | D | 16,160 | $0.00 | 0 | D | $1.64 · 2020-04-21 to 2027-04-21 | 16,160 Common Stock | (F3) Total number of shares became exercisable on this date. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-07-14 | M | D | 10,000 | $0.00 | 0 | D | $1.34 · 2020-11-20 to 2027-10-20 | 10,000 Common Stock | (F2) One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. |